F 0880
Provide and implement an infection prevention and control program.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to implement infection control measures to
prevent a scabies (a contagious skin condition caused by tiny insects called mites which infest and irritate
the skin causing intense itching, red patches, and inflammation [the immune system's response to harmful
stimuli]) outbreak (two or more clinically suspect or confirmed cases of scabies identified in
patients/residents, healthcare workers, volunteers and/or visitors during a six week time period) for five of
five sampled residents (Resident 1, 2, 3, 4, and 5) by failing to:1. Recognize a possible scabies outbreak
when Residents' 1,2,3,4 and 5 with suspected scabies were treated prophylactically (a medication or action
used to prevent disease or a recurrence of a condition) by the physician for scabies.These deficient
practices placed residents, staff, and visitors at risk of acquiring and spreading scabies. Findings: A. During
a review of Resident 1's admission Record (Face Sheet- front page of the chart), the Face Sheet indicated
Resident 1 was originally admitted to the facility on [DATE] and readmitted on [DATE] with diagnosis
including respiratory failure (a life threatening condition that occurs when the lungs cannot adequately get
oxygen into the blood or remove carbon dioxide from it), dysphagia (difficulty swallowing), and cerebral
infarction (occurs when a blood clot blocks an artery supplying the brain, leading to a lack of oxygen and
nutrients, causing brain tissue death). During a review of Resident 1's History and Physical (H&P), dated
11/5/2025, the H&P indicated Resident 1 had the capacity to understand and make decisions. During a
review of Resident 1's Minimum Data Set (MDS-a resident assessment tool), dated 11/10/2025, the MDS
indicated Resident 1 was dependent (helper does all the effort) on nursing staff for oral hygiene, showering,
dressing and transferring.During a review of Resident 1's Skin Assessment, dated 9/18/2025, the Skin
Assessment indicated Resident 1 had a rash eczematous dermatitis (a group of inflammatory skin
conditions that cause an itchy rash, dry skin, and inflammation) noted to be spreading to the generalized
body. The Skin Assessment indicated Resident 1 was seen and evaluated by Nurse Practitioner (NP) 1 and
received new orders for treatment for a diagnosis of unspecified dermatitis (a general term for skin
inflammation with an unknown cause, presenting with symptoms like redness, itching, and scaling). During
a review of Resident 1's Order Summary, dated 9/18/2025, the Order Summary indicated Resident 1 had
an order for contact precautions (safeguards used in healthcare settings to prevent the spread of germs
that are transmitted by direct or indirect contact with a resident or their environment) for a rash of unknown
origins every shift for four weeks. The Order Summary indicated Resident 1 had an order for Ivermectin
(anti-parasitic drug used to treat specific conditions caused by parasitic worms and external parasites) Oral
Tablet 3 milligrams ([mg] unit of measurement) to give 15 mg by gastric tube in the afternoon every Friday
for diagnosis of dermatitis unspecified for four administrations. The Order Summary indicated Resident 1
had an order for Permethrin (a medication used to treat parasites like scabies and lice) external cream 5
percent (%0 apply to the neck down to the toes topically at bedtime every Thursday for
Residents Affected - Some
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 5
Event ID:
055297
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055297
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/01/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Springs Post-Acute
10625 Leffingwell Road
Norwalk, CA 90650
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
diagnosis of dermatitis unspecified for four administrations. The Order Summary indicated to apply one
tube from the neck down to the toes and leave on for 12 hours and then rinse off.During a review of
Resident 1's Order Summary, dated 9/23/2025, the Order Summary indicated Resident 1 had an order for
During a review of Resident 1's Order Summary, dated 9/23/2025, the Order Summary indicated Resident
1 had an order for Ivermectin Oral Tablet 3 mg (mg- metric unit of measurement, used for medication
dosage and/or amount) give 15 mg by gastric tube (a surgical opening fitted with a device to allow feedings
to be administered directly to the stomach common for people with swallowing problems) in the afternoon
every Thursday for a diagnosis of dermatitis unspecified for three administrations. The Order Summary
indicated Resident 1 had an order for Permethrin external Cream 5 % apply to the neck down to the toes
topically at bedtime every Wednesday for a diagnosis of dermatitis unspecified for three administrations
apply one tube from the neck down to the toes, leave on for 12 hours then rinse off. During a review of
Resident 1's Dermatology Progress Note, dated 9/18/2025, the Dermatologist Note indicated Resident 1
had dermatitis unspecified to the generalized body. B. During a review of Resident 2's Face Sheet, the Face
Sheet indicated Resident 2 was admitted originally admitted to the facility on [DATE] and readmitted on
[DATE] with diagnosis including hemiplegia (paralysis affecting one side of the body, typically caused by
brain or spinal cord damage, often from stroke, traumatic brain injury, or congenital conditions like cerebral
palsy, leading to severe weakness or complete loss of movement, sensation, and coordination on the
affected side (face, arm, leg), dysphagia, and respiratory failure. During a review of Resident 2's H&P, dated
7/21/2025, the H&P indicated Resident 2 does not have the capacity to understand and make decisions.
During a review of Resident 2's MDS, dated [DATE], the MDS indicated Resident 2 was dependent on
nursing staff for oral hygiene, toileting, showering, dressing, and transferring. During a review of Resident
2's Skin Assessment, dated 9/19/2025, the Skin Assessment indicated Resident 2 had a diagnosis of
unspecified dermatitis on the back and a generalized body rash.During a review of Resident 2's Order
Summary, dated 9/18/2025, the Order Summary indicated Resident 2 had an order for contact precautions
for rash of unknown origins every shift for four weeks. The Order Summary dated indicated Resident 2 had
an order for Ivermectin Oral Tablet 3 mg to give 9 mg by gastric tube in the afternoon every Friday for
diagnosis of dermatitis unspecified for four administrations. The Order Summary indicated Resident 2 had
an order for Permethrin external cream 5 % apply to generalized body topically at bedtime for diagnosis of
dermatitis unspecified for four administrations, apply one tube from the neck down to the toes, and leave on
for 12 hours and then rinse off.During a review of Resident 2's Order Summary, dated 9/23/2025, the Order
Summary indicated Resident 2 had an order for Ivermectin Oral Tablet 3 mg (Ivermectin) give 9 mg by
gastric tube in the afternoon every Thursday for a diagnosis of dermatitis unspecified for three
administrations. The Order Summary indicated Resident 2 had an order for Permethrin external cream 5 %
apply to the neck down to the toes topically at bedtime every Wednesday for a diagnosis of dermatitis
unspecified for three administrations apply one tube from the neck down to the toes, leave on for 12 hours
then rinse off. Repeat once weekly for four weeks.During a review of Resident 2's Dermatology Progress
Note, dated 9/18/2025, the Dermatology Progress Note indicated Resident 2 had a rash located on the
body throughout. The Dermatology Progress Note indicated the rash was itchy, red, and scaly and
moderate in severity. The Dermatology Progress Note indicated Resident 2 had this rash for weeks with
difficulty sleeping at night due to itching. The Dermatology Progress Note indicated Resident 2 had a
Differential Diagnosis (DDx-the process of listing potential diseases or conditions that could be causing the
resident's symptoms, helping doctors narrow down possibilities to find the correct diagnosis) that included
scabies, dyshidrotic eczema ( a type of eczema
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055297
If continuation sheet
Page 2 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055297
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/01/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Springs Post-Acute
10625 Leffingwell Road
Norwalk, CA 90650
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
causing intensely itchy, fluid-filled blisters on the hands and feet), pruritus (itchy skin) and pediculosis
corporis (body lice). C. During a review of Resident 3's Face Sheet, the Face Sheet indicated Resident 3
was admitted to the facility on [DATE] with diagnosis of but not limited to encephalopathy (a broad term for
any disease, disorder, or damage that alters the brain), respiratory failure, dysphasia and hemiplegia.
During a review of Resident 3's H&P, dated 2/6/2025, the H&P indicated Resident 3 did not have the
capacity to understand and make decisions.During a review of Resident 3's MDS, dated [DATE], the MDS
indicated Resident 3 was dependent on nursing staff for oral hygiene, toileting, showering, dressing, and
transferring. During a review of Resident 3's Skin Assessment, dated 10/17/2025, the Skin Assessment
indicated Resident 3 was seen and evaluated regarding pimple like eruptions on the anterior thighs,
Resident 3's body was checked and noted with small eruptions on the trunk (torso), extending to the
general body. Resident 3 received diagnosis and orders for unspecified dermatitis. The rash appears red,
with scant serous exudate. Resident 3 complained about itchiness, skin on affected area is warm to touch.
During a review of Resident 3's Order Summary, dated 10/17/2025, the Order Summary indicated Resident
3 had an order for contact isolation precautions due to a rash of unknown origin. The Order Summary
indicated Resident 3 had an order for ivermectin Oral Tablet 3 mg (ivermectin) to give 12 mg by gastric tube
in the afternoon every Saturday for dermatitis unspecified for two administrations (4 tabs = 12mg). The
Order Summary indicated Resident 1 had an order for permethrin external cream 5 % apply from the neck
down to the toes topically at bedtime for dermatitis unspecified for two administrations. Apply one tube from
the neck down to the toes, leave for 12 hours then rinse off. Apply once weekly for two weeks. During a
review of Resident 3's Dermatology Progress Note, dated 11/13/2025, the Dermatology Progress Note
indicated Resident 3 had dermatitis unspecified to the generalized body.D. During a review of Resident 4's
Face Sheet, the Face Sheet indicated Resident 4 was admitted to the facility on [DATE] with diagnosis of
but not limited to hemiplegia, respiratory failure, sepsis (a life-threatening blood infection0 and seizures(a
sudden, uncontrolled electrical disturbance in the brain which can cause uncontrolled jerking, blank stares,
and loss of consciousness). During a review of Resident 4's H&P, dated 10/2/2025, the H&P indicated
Resident 4 had fluctuating capacity to understand and make decisions. During a review of Resident 4's
MDS, dated [DATE], the MDS indicated 4 was dependent on nursing staff for oral hygiene, toileting,
showering, dressing and transferring. During a review of Resident 4's Skin Assessment, dated 10/17/2025,
the Skin Assessment indicated Resident 4 had a rash diagnosed as dermatitis unspecified on the
generalized body with redness, scant serous drainage, and warm to the touch. During a review of Resident
4's Order Summary, dated 10/17/2025, the Order Summary indicated Resident 4 had an order for contact
isolation precautions due to rash of unknown origins. The Order Summary indicated Resident 4 had an
order for ivermectin Oral Tablet 3 mg (ivermectin) to give four tablets by gastric-tube one time a day every
Saturday for a diagnosis of unspecified dermatitis for four administrations (4 TAB =12 mg). The Order
Summary Indicated Resident 4 had an order for permethrin external cream 5 % to apply to the neck down
to the toes topically at bedtime every Friday for a diagnosis of dermatitis unspecified for four administrations
apply one tube from the neck down to the toes and leave on for 12 hours and then rinse off, once weekly for
4 administrations.During a review of Resident 4's Dermatology Progress Note, dated 11/13/2025, the
Dermatology Progress Note indicated Resident 4 had dermatitis unspecified to the generalized body.\ E.
During a review of Resident 5's Face Sheet, the Face Sheet indicated Resident 5 was admitted to the
facility on [DATE] with diagnosis of but not limited to cerebral infarction, aphasia (a disorder that makes it
difficult to speak), respiratory failure and dysphagia.During a review of Resident 5's H&P, date 8/29/2025,
the H&P indicated Resident
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055297
If continuation sheet
Page 3 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055297
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/01/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Springs Post-Acute
10625 Leffingwell Road
Norwalk, CA 90650
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
5 did not have the capacity to understand and make decisions.During a review of Resident 5's MDS, dated
[DATE], the MDS indicated Resident 5 was dependent on nursing staff for oral hygiene, toileting, showering,
dressing and transferring. During a review of Resident 5's Skin Assessment, dated 11/4/2025, the Skin
Assessment indicated Resident 5 had a rash like redness on the back of the right arm extending to right
side, scattered multiple red spots, pimple like eruptions, and scant serous (clear watery part of blood)
exudate (a protein-rich fluid that leaks out of blood vessels into nearby tissues or onto a surface as a result
of inflammation or injury). The Skin Assessment indicated Resident 5 complained of itchiness. The Skin
Assessment indicated Resident 5 was referred to Dermatology and diagnosed with dermatitis unspecified.
During a review of Resident 5's Order Summary, dated 11/3/2025, the Order Summary indicated Resident
5 had an order for Contact Isolation precautions due to a rash diagnosed as unspecified dermatitis. During
a review of Resident 5's Order Summary, dated 11/4/2025, the Order Summary indicated Resident 5 had
an order for ivermectin Oral Tablet 3 mg give four tablets by gastric tube in the afternoon every Wednesday
for a diagnosis of dermatitis unspecified for four administrations. The Order Summary Indicated Resident 5
had an order for permethrin external cream 5 % to apply to the neck down to the toes topically at bedtime
every Tuesday for a diagnosis of dermatitis unspecified for four administrations, apply one tube from the
neck down to the toes, leave on for 12 hours and then rinse off. During a review of Resident 5's Order
Summary, dated 11/28/2025, the Order Summary indicated Resident 5 had an order for permethrin
external cream 5 % to apply to the neck down to the toes topically at bedtime every Tuesday for a diagnosis
of dermatitis unspecified for two administrations, apply one tube from the neck down to the toes, leave on
for 12 hours and then rinse off, give two more administrations. The Order Summary indicated Resident 5
had an order for Permethrin-Nit Remover Combination Kit 0.25 % to apply to the scalp topically one time a
day every Wednesday for hair mites. For two administrations apply to the scalp, leave in for 10 minutes and
rinse off.\During a review of Resident 5's Dermatology Progress Note, dated 11/3/2025, the Dermatologist
Note indicated Resident 5 had a rash throughout the body. The Dermatology Progress Note indicated the
rash as itchy, red, scaly, and moderate in severity. The Dermatology Progress Note indicated Resident 5
had this rash for weeks. The Dermatology Progress Note indicated Resident 5 had difficulty sleeping at
night due to itch. The Dermatology Progress Note indicated Resident 5 had scabietic nodules and
erythematous eczematous patches distributed on the body throughout. The Dermatology Progress Note
indicated Resident 5 had a diagnosis that included scabies, contact dermatitis, and dyshidrotic eczema.
During a review of Resident 5's Dermatology Progress Note, dated 11/13/2025, the Dermatology Progress
Note indicated Resident 5 had dermatitis unspecified to the generalized body.During an interview on
11/26/2025 at 11:55 a.m. with [NAME] Certified Nursing Assistant (CNA) 1, CNA 1 stated she gave a
shower to Resident 5 on Wednesday. CNA 1 stated she is not sure why Resident 5 has contact
precautions. CNA 1 stated Resident 5 contact precautions could be for scabies. CNA 1 stated she gave a
shower with special soap and cream for scabies for the residents in room [ROOM NUMBER]. During an
interview on 11/26/2025 at 12:34 p.m., with Licensed Vocational Nurse (LVN) 1, LVN 1 stated Resident 5
has unspecified dermatitis, and the roommates are on contact precautions due to Resident 5's diagnosis of
dermatitis unspecified. LVN 1 stated Resident 5 was treated with Permethrin external cream and Ivermectin
for dermatitis unspecified.During an interview on 11/26/2025 at 1:06 p.m., with LVN 2, LVN 2 stated on
11/3/2025 it was reported Resident 5 had a rash on the posterior right arm and the trunk. LVN 2 stated the
dermatologist was notified on 11/3/2025 and Resident 5 was diagnosed with dermatitis unspecified. LVN
stated Resident 5 was given permethrin and ivermectin on 11/4/2025 to treat unspecified dermatitis. LVN 2
stated we place resident on contact precautions
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055297
If continuation sheet
Page 4 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055297
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/01/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
The Springs Post-Acute
10625 Leffingwell Road
Norwalk, CA 90650
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
diagnosed with dermatitis unspecified due to the unknown origin. During an interview on 12/1/2025 at 11:21
a.m. with the Infection Preventionist Nurse (IPN), the IPN stated scabies are reported to the department of
health right away when diagnosed. The IPN stated the doctor will order a skin scraping for scabies, if the
doctor suspects it. The IPN stated that she can also ask the doctor for an order for skin scraping if scabies
are suspected. The IPN stated the residents and roommates are placed on contact isolation precautions.
IPN stated the residents are monitored for skin changes and treated as ordered with Ivermectin cream,
Permethrin, and scheduled showers. The IPN stated resident diagnosed with dermatitis unspecified get
medication for scabies because they did not know the origin of the rash. The IPN stated no testing for
scabies was done before administering scabies medication. The IPN stated she could have suggested skin
scraping but she did not. The IPN stated the residents completed the full course of medication. During an
interview on 12/1/2025 at 2:15 p.m. with the Director of Nursing (DON), the DON stated residents
diagnosed with unspecified dermatitis are given Permethrin and Ivermectin prophylactically. The DON
stated the medicine for scabies is necessary to treat dermatitis. The DON stated residents are placed on
contact precautions when scabies are suspected. The DON stated suspected scabies are not reportable,
only confirmed cases are reported. During an interview on 12/2/2025 at 9:06 a.m. with the Dermatologist
Medical Doctor (DMD), the DMD stated unspecified dermatitis could be possible scabies or eczema. The
DMD stated that unspecified dermatitis is treated with medication for scabies prophylactically when scabies
are suspected. The DMD stated it is standard for the facility to isolate, report and test residents with
suspected scabies. During a review of the facility's policy and procedure (P&P), titled Scabies Identification,
Treatment and Environmental Cleaning, date revised 8/2022, the P&P indicated, The purpose of this
procedure is to treat residents infected with and sensitized to Sarcoptes scabiei (The itch mite is a parasitic
mite found in all parts of the world that burrows into skin and causes scabies) and to prevent the spread of
scabies to other residents and staff.
Event ID:
Facility ID:
055297
If continuation sheet
Page 5 of 5